Health
Sacramento selected as COVID-19 vaccine trial site – KCRA Sacramento
Sacramento has been selected as a site for a COVID-19 vaccine trial. Both UC Davis Medical Center and Kaiser Permanente are participating in the vaccine trial through a partnership with Pfizer.
SACRAMENTO, Calif. —Sacramento has been selected as a site for a COVID-19 vaccine trial. Both UC Davis Medical Center and Kaiser Permanente are participating in the vaccine trial through a partnership with Pfizer.
The trial will span 120 locations with a goal of including 30,000 applicants worldwide.
What we want the community to know is that this is really important research. Its a first step in developing a vaccine for COVID, UC Davis Medical School Dean Allison Brashear said.
UC Davis Me…
-
General16 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Business21 hours agoThese ASX 200 shares could rise 55% to 65%
-
Noosa News23 hours agoBarn-owl project reducing farmers’ reliance on poison to manage rats and mice
-
Noosa News20 hours agoSouth-west Queensland highway closed after truck carrying oxygen cylinders catches fire